NOWVF yields 1114.83% · JNJ yields 2.13%● Live data
📍 NOWVF pulled ahead of the other in Year 1
Combined, NOWVF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NOWVF + JNJ for your $10,000?
NowVertical Group Inc. operates as a big data technology company. Its vertical intelligence software and services solutions address industry-specific needs in the areas of data transformation, data visualization and analysis, and artificial intelligence and automation. The company's proprietary technologies include NOW Fusion, a database fusion technology that brings together structured and unstructured data from both inside and outside an organization to drive enhanced business analysis; NOW Privacy and NOW Reveal software solutions, which adds governance and compliance layer to an organization's data; NOW DataBench, a unified analytics operating framework that brings business intelligence tools into a single interface to make informed decisions using their data; and Affinio, a data mobilization solution. It also provides solutions to government, financial services, energy and renewables, automotive manufacturers, brands and advertisers, and enterprises. The company is headquartered in West Palm Beach, Florida.
Full NOWVF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.